Biologics Engineering, Computational and Experimental Design of Multispecific Antibodies Intern
AstraZeneca
Summary
We are looking for rising seniors and Master's level students studying Chemical Engineering, Biological Engineering or a related field for a 12-week internship role at our site in Gaithersburg, MD from May 24, 2027 to August 13, 2027.
Job description
Position Description
- Design multispecific antibodies using computational and AI-enhanced approaches.
- Produce multispecific antibodies using appropriate expression and purification workflows.
- Characterize multispecific antibodies through functional and biophysical assays.
Position Requirements
- Rising seniors and Master's level students studying Chemical Engineering, Biological Engineering or a related field.
- Required experience includes computational protein modeling/design and protein engineering.
- Required wet-lab skills include molecular cloning, protein purification, and in vitro and cell-based assays.
- Candidates must have an expected graduation date after August 2027.
- US Work Authorization is required at time of application.
- This role will not be granting CPT support.
- Ability to report onsite to Gaithersburg, MD site 5 days per week. This role will not provide relocation assistance.
Requirements
- Rising seniors and Master's level students studying Chemical Engineering, Biological Engineering or a related field
- Computational protein modeling/design and protein engineering experience
- Wet-lab skills: molecular cloning, protein purification, in vitro and cell-based assays
- Expected graduation date after August 2027
- US Work Authorization required at time of application
- No CPT support
- Ability to report onsite to Gaithersburg, MD 5 days per week
- No relocation assistance
Benefits
- Hourly compensation $39 - $41.50
Company overview
AstraZeneca is a global, science-led, patient-focused pharmaceutical company dedicated to accelerating the delivery of life-changing medicines that create enduring value for patients, society, and shareholders. With a workforce of over 94,300 employees worldwide, the company operates across three core therapy areas: Oncology, BioPharmaceuticals (including Cardiovascular, Renal & Metabolism, Respiratory & Immunology), and Rare Disease. Headquartered in Cambridge, UK, AstraZeneca maintains strategic R&D centers in Cambridge, Gaithersburg (US), Boston (US), Gothenburg (Sweden), Shanghai, and Beijing. The company generated $54.1 billion in total revenue in 2024 and invested $13.6 billion in scientific research and development. AstraZeneca's bold aspiration is to be pioneers in science, lead in disease areas, and transform patient outcomes, with a goal to launch 20 new medicines and achieve $80 billion in total revenue by 2030. The company is recognized for its commitment to sustainability, health equity, and creating an inclusive work environment where diverse perspectives drive innovation.